DOD Biotech PCL

DOD Biotech PCL EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of DOD Biotech PCL (DOD.BK) as of Oct 10, 2026 is 27.09 M THB. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 43.49 M THB — a change of -37.72% (lower).

EBITDA

27.09 MTHB

YoY

-37.72%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of DOD Biotech PCL is 2025 27.09 M THB. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of DOD Biotech PCL was 2024 43.49 M THB. It decreases by -37.72% lower compared to the previous year.

The DOD Biotech PCL EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
311.36 M THB
Jan 1, 2019
87.79 M THB
Jan 1, 2020
330.81 M THB
Jan 1, 2021
271.52 M THB
Jan 1, 2022
-412.56 M THB
Jan 1, 2023
56.89 M THB
Jan 1, 2024
43.49 M THB
Jan 1, 2025
27.09 M THB
The DOD Biotech PCL EBITDA history
YEAREBITDAYoY
27.09 MTHB-37.72%
43.49 MTHB-23.55%
56.89 MTHB-113.79%
-412.56 MTHB-251.94%
271.52 MTHB-17.92%
330.81 MTHB+276.81%
87.79 MTHB-71.80%
311.36 MTHB+125.47%
138.09 MTHB+4.80%
131.77 MTHB+178.78%
47.27 MTHB-9,616.53%
-496,692.24THB—
Access this data via the Eulerpool API
Get Free API Key

DOD Biotech PCL Stock analysis

What does DOD Biotech PCL do? DOD Biotech PCL is a Thai biotechnology company specializing in the production of pharmaceuticals, diagnostics, and research products. Established in 2004, the company has become one of the most reputable biotechnology companies in Thailand. Its business model is based on the development and manufacturing of products used in medicine, veterinary medicine, and research. DOD Biotech PLC focuses on continually evolving and adapting its products to meet customer needs. Its main areas of focus are the production of pharmaceuticals, particularly anti-cancer drugs, diabetes medications, cardiovascular medications, and infection treatments. Additionally, the company manufactures diagnostics for disease early detection and precise diagnosis. It also offers a variety of products for research purposes. DOD Biotech PCL has partnerships with several companies in other countries, particularly in Asia and Europe. Its largest partner is the Indian company Sun Pharma, with which it has had a successful collaboration for many years. The company is known for its high-quality standards and is certified to ISO 9001:2015 and follows the Good Manufacturing Practices (GMP) required by the Thai FDA. DOD Biotech PCL has received international recognition, including the Frost & Sullivan Thailand Excellence Award and being recognized as a top 30 company in Thailand in 2020. Over the years, the company has built a loyal customer base that appreciates its high-quality products and excellent customer service. It has a strong online presence to better reach and serve its customers. In summary, DOD Biotech PCL is a leading biotechnology company in Thailand with a wide range of pharmaceuticals, diagnostics, and research products. It has earned an excellent reputation for its high-quality standards and top-notch customer service. With its strong online presence and partnerships with other companies in Asia and Europe, DOD Biotech PCL will undoubtedly remain an important player in the global healthcare market in the future. DOD Biotech PCL is one of the most popular companies on Eulerpool.

Frequently Asked Questions about DOD Biotech PCL stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of DOD Biotech PCL is 27.09 M THB in 2025.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of DOD Biotech PCL changed from 43.49 M THB to 27.09 M THB, representing a -37.72% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) DOD Biotech PCL since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s THB is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s DOD Biotech PCL historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — DOD Biotech PCL

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — DOD Biotech PCL